On October 5, 2023 Vedanta Biosciences, a clinical-stage biopharmaceutical company pioneering the development of oral therapies based on defined bacterial consortia, reported that members of its executive team will participate at the following investor conferences (Press release, Vedanta Biosciences, OCT 5, 2023, View Source [SID1234635689]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BMO Life Sciences Private Company Showcase

Presentation Date: October 12, 2023

Presentation Time: 2:55 p.m. ET

Location: The New Your Times Building, New York, NY

Leerink Partners Biopharma Private Company Connect

Dates: October 25-26, 2023

Virtual 1×1 meetings only